Long-term follow-up and predictors of target lesion failure after implantation of everolimus-eluting bioresorbable scaffolds in real-world practice.
Wiebe J, Baquet M, Dörr O, Hoppmann P, Jochheim D, Rheude T, Boeder N, Grundmann D, Blachutzik F, Theiss H, Cassese S, Hofmann FJ, Gschwendtner S, Elsässer A, Massberg S, Hamm C, Laugwitz KL, Byrne RA, Mehilli J, Kastrati A, Nef H.
Wiebe J, et al. Among authors: baquet m.
Int J Cardiol. 2020 Aug 1;312:42-47. doi: 10.1016/j.ijcard.2020.02.062. Epub 2020 Feb 27.
Int J Cardiol. 2020.
PMID: 32151443